fda update on tirzepatide is approved for obesity Breaking News: Approves Treating FDA Approves Diabetes Drug Tirzepatide – Tirzepatide, FDA, and Compounding: Understanding

State Reconstituted (Liquid Form) Storage 35.6-46.4F (2-8C) Notes Faint blue tint is normal from the copper complex

Formulated to encourage GLP-1 release Great-tasting and convenient Designed to reduce cravings, and support fat metabolism These drinks are a smart alternative to injections they support your metabolic health, help curb the urge to snack, and assist in building lean body mass

This multi-action mechanism helps manage blood glucose while promoting weight loss, setting Tirzepatide apart from other GLP-1 agonists that target only the GLP-1 pathway

Co-formulated (3 vials): CJC-1295 (No DAC) 5 mg, Ipamorelin 5 mg, BPC-157 + TB-500 combined vial 10 mg total